The WHO's Strategic Advisory Group of Experts recommends that immunocompromised people receive a third dose of the vaccine due to the risk of breakthrough infections after standard immunization. The panel also recommends that people over the age of 60 receive an additional dose of the Sinopharm or Sinovac vaccine three months after their second dose, citing the performance of the vaccines in Latin America.
The WHO's Strategic Advisory Group of Experts recommends that immunocompromised people to receive third dose of the vaccine due to risk of breakthrough infections after standard immunization. The panel also recommends people aged over 60 to receive additional dose of the Sinopharm and Sinovac vaccines three months after their second dose citing the less performed vaccine in Latin America.
The WHO's Strategic Advisory Group of Experts recommends that immunocompromised people receive athird dose of the vaccine due to therisk of breakthrough infections after standard immunization. The panel also recommends thatpeople overtheage of 60 receive anadditional dose of the Sinopharm or Sinovac vaccine three months after their second dose, citing the performance ofthevaccines in Latin America.
